Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 20921465

Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: the PRIME study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2010 Nov 1
First author
Douillard JY

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2010 Nov 1;28(31):4668-70. doi: 10.1200/JCO.2010.29.3407.
    note
    Source null
    related pmid
    20921457
    relationship
    Comment in
  2. citation
    Future Oncol. 2011 Feb;7(2):223-6. doi: 10.2217/fon.10.181.
    note
    Source null
    related pmid
    21345141
    relationship
    Comment in
  3. citation
    Nat Rev Clin Oncol. 2010 Dec;7(12):672. doi: 10.1038/nrclinonc.2010.176.
    note
    Source null
    related pmid
    21542198
    relationship
    Comment in

Authors and identifiers

  1. name
    Douillard JY
    type
    Author
  2. name
    Siena S
    type
    Author
  3. name
    Cassidy J
    type
    Author
  4. name
    Tabernero J
    type
    Author
  5. name
    Burkes R
    type
    Author
  6. name
    Barugel M
    type
    Author
  7. name
    Humblet Y
    type
    Author
  8. name
    Bodoky G
    type
    Author
  9. name
    Cunningham D
    type
    Author
  10. name
    Jassem J
    type
    Author
  11. name
    Rivera F
    type
    Author
  12. name
    Kocákova I
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Douillard JY
    type
    Author
  2. name
    Siena S
    type
    Author
  3. name
    Cassidy J
    type
    Author
  4. name
    Tabernero J
    type
    Author
  5. name
    Burkes R
    type
    Author
  6. name
    Barugel M
    type
    Author
  7. name
    Humblet Y
    type
    Author
  8. name
    Bodoky G
    type
    Author
  9. name
    Cunningham D
    type
    Author
  10. name
    Jassem J
    type
    Author
  11. name
    Rivera F
    type
    Author
  12. name
    Kocákova I
    type
    Author
bibliography ids
  1. nci-bib-59ca45d32774d62ce1a09451
book metadata
content sha256
976ed5d6e445af2049082bc29cfee9f573817d52df7106c9615b4ab86cc7aa02
document type
citation
dois
  1. 10.1200/JCO.2009.27.4860
electronic publication date
display
2010 Oct 4
precision
day
year
2010
evidence scope
bibliographic_metadata_only
id
pubmed:20921465
immutable id
pubmed:20921465@976ed5d6e445af2049082bc29cfee9f573817d52df7106c9615b4ab86cc7aa02
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
31
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
4697-705
volume
28
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2010 Nov 1;28(31):4668-70. doi: 10.1200/JCO.2010.29.3407.
    note
    Source null
    related pmid
    20921457
    relationship
    Comment in
  2. citation
    Future Oncol. 2011 Feb;7(2):223-6. doi: 10.2217/fon.10.181.
    note
    Source null
    related pmid
    21345141
    relationship
    Comment in
  3. citation
    Nat Rev Clin Oncol. 2010 Dec;7(12):672. doi: 10.1038/nrclinonc.2010.176.
    note
    Source null
    related pmid
    21542198
    relationship
    Comment in
outcomes validated
false
pmid
20921465
provenance
batch id
10a38257e12e9ed1867a
provider
NCBI PubMed ESummary
record sha256
c474e7909b1c84619c73e646a289ed296c1f9bcec2a1d9e35e00f288dc21c324
response sha256
84c4808ca38b35d999cfdf809eb088835175ab38d71586c626096d677096bbcc
retrieved at
2026-09-09T23:46:35.793530+00:00
publication date
display
2010 Nov 1
precision
day
year
2010
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/20921465/
title
Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: the PRIME study.

Preserved source evidence · Independent clinical review pending · Not medical advice